Health
Unapproved Gene Therapy for Longevity
A US company is set to offer an unapproved gene therapy that boosts the production of klotho protein at overseas clinics. This bypasses FDA regulations and could have significant implications for longevity treatments.
Coverage timeline — 1 article
New Scientist
A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules
2026-06-23 12:14 UTC